From Bare to Covered

Butera, Gianfranco; Mânica, João Luiz; Marini, Davide; Piazza, Luciane; Chessa, Massimo; Filho, Raul Ivo Rossi; Leite, Rogério E. Sarmento; Carminati, Mário

doi:10.1002/ccd.25404

Cited by 48 publications

(22 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although stent fractures have been observed after CoA stenting, 2,7,10,22,30,31 historically, their frequency has seemed to be lower than observed rates in other vascular territories such as right ventricle-topulmonary artery conduits and pulmonary arteries in which the mechanical stressors and risk factors for fracture are more thoroughly understood. In the present cohort, although no stent fractures were observed immediately after stent placement, we have observed some degree of stent fracture in 23 subjects during follow-up, with evidence of progression of stent fractures from single to multiple struts.…”

Section: Stent Fracturementioning

confidence: 97%

“…2,7,10,33 There is some evidence that acute AWI is more likely to occur with smaller initial coarctation diameters, with larger ratios of balloon to minimal aortic diameter, and when stent placement is preceded by balloon angioplasty, 1,34 whereas predictors of late AWI are less well understood. Although several patients in this study received CCPS therapy at the discretion of their interventional cardiologist, we observed acute AWI, both small aortic aneurysms, in only 2 patients, a rate similar to prior publications.…”

Section: Aortic Wall Injurymentioning

confidence: 99%

See 1 more Smart Citation

Intermediate Outcomes in the Prospective, Multicenter Coarctation of the Aorta Stent Trial (COAST)

et al. 2015

View full text Add to dashboard Cite

Background-The Coarctation of the Aorta Stent Trial (COAST) was designed to assess the safety and efficacy of the Cheatham Platinum stent when used in children and adults with native or recurrent coarctation. Acute outcomes have been reported. We report here follow-up to 2 years. Methods and Results-A total of 105 patients underwent attempted implantation, with 104 successes. There were no procedural deaths, serious adverse events, or surgical intervention. All patients experienced immediate reduction in upperto lower-extremity blood pressure difference with sustained improvement to 2 years. Rates of hypertension and medication use decreased from baseline to 12 months and remained largely unchanged at 2 years. Six aortic aneurysms have been identified: 5 were successfully treated with covered stent placement, and 1 resolved without intervention. Stent fractures were noted in 2 patients at 1 year and 11 patients at 2 years, with evidence of fracture progression. To date, only larger stent diameter was associated with stent fracture. Twelve additional fractures have occurred after 2 years. No fracture has resulted in loss of stent integrity, stent embolization, aortic wall injury, or reobstruction. Nine reinterventions occurred in the first 2 years for stent redilation and address of aneurysms, and 10 additional reinterventions occurred after 2 years. Conclusions-The Cheatham Platinum stent is safe and associated with persistent relief of aortic obstruction. Stent fracture and progression of fracture occur but have not resulted in clinically important sequelae. Reintervention is common and related to early and late aortic wall injury and need for re-expansion of small-diameter stents. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00552812.

show abstract

Section: Stent Fracturementioning

confidence: 97%

Section: Aortic Wall Injurymentioning

confidence: 99%

Intermediate Outcomes in the Prospective, Multicenter Coarctation of the Aorta Stent Trial (COAST)

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Compared to bare metal stent, covered stent use is associated with lower in-stent restenosis rate and lower aortic complications in patients with aortic coarctation. 20,21 Thus, covered stent yields a good result in the management of MAS. Previous studies of MAS using endovascular intervention are summarized in Table I.…”

Section: Discussionmentioning

confidence: 96%

Late presentation of middle aortic syndrome complicated with severe aortic regurgitation; the role of endovascular intervention as a bridging for Bentall surgery

Indriani

Erriyanti

Dewangga

et al. 2022

Journal of Vascular Surgery Cases, Innovations and Techniques

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

“…Na rozdíl od literárních údajů v našem souboru překvapivě převládaly nativní koarktace nad rekoarktací [9][10][11][12]. Celkově jsou publikované soubory malé i z velkých center [13,14]. Použití moderních stentů s nízkým profi lem zavaděčů a šicích zařízení k ošetření nepreparovaného třísla při použití stentgraftů umožňuje zákroky provádět v lokální anestezii.…”

Section: Souborunclassified

Endovascular management of coarctation of the aorta in adult patients

Novotný

Peregrin

2015

Cor Vasa

View full text Add to dashboard Cite

Úvod: Koarktace patří mezi vrozené srdeční vady s výskytem 5-8 %, častější je u chlapců, převážná většina pacientů je ale již v dětském věku operována. U mladistvých a dospělých převládá v současné době endovaskulární léčba. Metoda: Použili jsme všechny tři obvyklé způsoby katetrizační léčby: prostou balonkovou dilataci, implantaci stentu, implantaci stentgraftu. Všichni léčení podstoupili před výkonem a po výkonu CT angiografi i. Soubor: Mezi roky 2004 a 2014 jsme léčili deset pacientů s koarktací-sedm mužů, tři ženy v průměrném věku 41,1 roku (21-59 let). U osmi jsme léčili nativní koarktaci, u dvou jsme léčili rekoarktaci. Dominantním znakem byla hypertenze (osm pacientů) a levostranné srdeční selhání (čtyři pacienti) (u některých nemocných bylo více znaků). Prostou dilataci jsme provedli u dvou nemocných, čtyřem jsme implantovali stent a čtyřem stentgraft. Výsledky: Technicky úspěšní jsme byli u všech pacientů. Dlouhodobý pozitivní léčebný účinek se projevil u všech. U všech osmi nemocných s hypertenzí došlo ke zlepšení, medikace byla snížena u čtyř a další čtyři jsou bez medikace.

show abstract

From Bare to Covered

Abstract: Both bare and covered stent implantation for aortic coarctation is a safe and efficacious treatment. By using covered stent implantation the spectrum of patients treated has increased with lower rates of acute and late complications.

Cited by 48 publications

References 39 publications

Intermediate Outcomes in the Prospective, Multicenter Coarctation of the Aorta Stent Trial (COAST)

Intermediate Outcomes in the Prospective, Multicenter Coarctation of the Aorta Stent Trial (COAST)

Late presentation of middle aortic syndrome complicated with severe aortic regurgitation; the role of endovascular intervention as a bridging for Bentall surgery

Endovascular management of coarctation of the aorta in adult patients

Contact Info

Product

Resources

About